Interrelationship between exposure to PCDD/Fs and hypertension in metabolic syndrome in Taiwanese living near a highly contaminated area

Chemosphere

Volumn 81, Issue 8, 2010, Pages 1027-1032

  Chang, J W ^a   Ou, H Y ^b   Chen, H L ^c   Guo, H R ^a,d   Liao, P C ^a,d   Lee, C C ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Blood pressure; Dioxin; Glycemia; Lipidemia; Metabolic syndrome

Indexed keywords

BLOOD; BLOOD PRESSURE; METABOLISM; RISK ASSESSMENT;

CARDIO-VASCULAR DISEASE; DIASTOLIC BLOOD PRESSURES; DIOXIN; GLYCEMIA; LIPIDEMIA; METABOLIC SYNDROMES; PERSISTENT ORGANIC POLLUTANT (POP); POSITIVE CORRELATIONS;

ORGANIC POLLUTANTS;

DIOXIN; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN;

ABNORMALITY; BODY SIZE; CARDIOVASCULAR DISEASE; CONCENTRATION (COMPOSITION); DIABETES; DISEASE PREVALENCE; FACTOR ANALYSIS; HEALTH IMPACT; HEALTH RISK; HYPERTENSION; METABOLISM; ORGANIC POLLUTANT; PCDD; PCDF; POLLUTION EFFECT; POLLUTION EXPOSURE; RISK FACTOR; SERUM;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY SIZE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; FACTORIAL ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RISK FACTOR; STATISTICAL SIGNIFICANCE; TAIWAN; WAIST CIRCUMFERENCE;

TAIWAN;

EID: 77957894955     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2010.08.050     Document Type: Article

References (41)

1. Balkau B., Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 1999, 16:442-443.
2. Bureau of Health Promotion, 2007. The Criteria of Metabolic Syndrome (in Chinese) <> (accessed 25.12.07.). http://www.bhp.doh.gov.tw/BHPnet/Portal/Them_Show.aspx?Subject=200712250023&Class=2&No=200712250123.
3. Chang J.W., Chen H.L., Su H.J., Liao P.C., Guo H.R., Lee C.C. Dioxin exposure and insulin resistance in Taiwanese living near a highly contaminated area. Epidemiology 2010, 21:56-61.
4. Cheal K.L., Abbasi F., Lamendola C., McLaughlin T., Reaven G.M., Ford E.S. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004, 53:1195-1200.
5. Chen H.L., Liao P.C., Su H.J., Guo Y.L., Chen C.H., Lee C.C. Profile of PCDD/F levels in serum of general taiwanese between different gender, age and smoking status. Sci. Total Environ. 2005, 337:31-43.
6. Chen H.L., Su H.J., Lee C.C. Patterns of serum PCDD/Fs affected by vegetarian regime and consumption of local food for residents living near municipal waste incinerators from Taiwan. Environ. Int. 2006, 32:650-655.
7. Chen H.L., Su H.J., Guo Y.L., Liao P.C., Hung C.F., Lee C.C. Biochemistry examinations and health disorder evaluation of Taiwanese living near incinerators and with low serum PCDD/Fs levels. Sci. Total Environ. 2006, 366:538-548.
8. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
9. Goff D.C., Zaccaro D.J., Haffner S.M., Saad M.F. Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2003, 26:805-809.
10. Ha M.H., Lee D.H., Jacobs D.R. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence. Results from the National Health and Nutrition Examination Survey, 1999-2002. Environ. Health Perspect. 2007, 115:1204-1209.
11. Ha M.H., Lee D.H., Son H.K., Park S.K., Jacobs D.R. Association between serum concentrations of persistent organic pollutants and prevalence of newly diagnosed hypertension: results from the National Health and Nutrition Examination Survey 1999-2002 Persistent organic pollutants and hypertension. J. Hum. Hypertens. 2009, 23:274-286.
12. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 1995, 35:307-340.
13. Hanley A.J., Karter A.J., Festa A., D'Agostino R., Wagenknecht L.E., Savage P. Insulin resistance atherosclerosis S: factor analysis of metabolic syndrome using directly measured insulin sensitivity: the insulin resistance atherosclerosis study. Diabetes 2002, 51:2642-2647.
14. Hokanson R., Miller S., Hennessey M., Flesher M., Hanneman W., Busbee D. Disruption of estrogen-regulated gene expression by dioxin: downregulation of a gene associated with the onset of non-insulin-dependent diabetes mellitus (type 2 diabetes). Hum. Exp. Toxicol. 2004, 23:555-564.
15. Joy T., Lahiry P., Pollex R.L., Hegele R.A. Genetics of metabolic syndrome. Curr. Diabetes Rep. 2008, 8:141-148.
16. Kopf P.G., Huwe J.K., Walker M. Hypertension, cardiac hypertrophy, and impaired vascular relaxation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are associated with increased superoxide. Cardiovasc. Toxicol. 2008, 8:181-193.
17. Kuusisto J., Lempiainen P., Mykkanen L., Laakso M. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care 2001, 24:1629-1633.
18. Lee C.C., Lin W.T., Liao P.C., Su H.J., Chen H.L. High average daily intake of PCDD/Fs and serum levels in residents living near a deserted factory producing pentachlorophenol (PCP) in Taiwan: influence of contaminated fish consumption. Environ. Pollut. 2006, 141:381-386.
19. Lee C.C., Guo Y.L., Kuei C.H., Chang H.Y., Hsu J.F., Wang S.T., Liao P.C. Human PCDD/PCDF levels near a pentachlorophenol contamination site in Tainan, Taiwan. Chemosphere 2006, 65:436-448.
20. Lee D.H., Lee I.K., Jin S.H., Steffes M., Jacobs D.R. Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2007, 30:622-628.
21. Lee D.H., Lee I.K., Porta M., Steffes M., Jacobs D.R. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 2007, 50:1841-1851.
22. Liu P.C., Matsumura F. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the "adipose-type" and "braintype" glucose transporters in mice. Mol. Pharmacol. 1995, 47:65-73.
23. Marchand A., Tomkiewicz C., Marchandeau J.P., Boitier E., Barouki R., Garlatti M. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces insulin-like growth factor binding protein-1 gene expression and counteracts the negative effect of insulin. Mol. Pharmacol. 2005, 67:444-452.
24. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
25. Meigs J.B. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am. J. Epidemiol. 2000, 152:908-911.
26. Merrill M.L., Baston D.S., Denison M.S., Birnbaum L.S., Pomp D., Threadgill D.W. Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E203-E210.
27. Michalek J.E., Pirkle J.L., Caudill S.P., Tripathi R.C., Patterson D.G., Needham L.L. Pharmacokinetics of TCDD in veterans of operation ranch hand: 10-year follow-up. J. Toxicol. Environ. Health 1996, 47:209-220.
28. Murphy L.J. The role of the insulin-like growth factors and their binding proteins in glucose homeostasis. Exp. Diabesity Res. 2003, 4:213-224.
29. Olson, J.R., Pharmacokinetics of dioxins and related compounds. In: Schecter, A. (Ed.), Dioxins and Health. Plenum Press, New York, 1994, pp. 163-189.
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285, pp. 2486-2497.
31. Pesatori A.C., Zocchetti C., Guercilena S., Consonni D., Turrini D., Bertazzi P.A. Dioxin exposure and non-malignant health effects: a mortality study. Occup. Environ. Med. 1998, 55:126-131.
32. Pirkle J.L., Caudell S.P., Patterson D.G., Needham L.L. Determinants of TCDD half-life in veterans of Operation Ranch Hand, J. Toxicol. Environ. Health 1994, 41:481-488.
33. Porta M. Persistent organic pollutants and the burden of diabetes. Lancet 2006, 368:558-559.
34. Remillard R.B., Bunce N.J. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ. Health Perspect. 2002, 110:853-858.
35. Skott P., Hother-Nielsen O., Bruun N.E., Giese J., Nielsen M.D., Beck-Nielsen H. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989, 32:694-699.
36. Sowers J.R., Frohlich E.D. Insulin and insulin resistance. Impact on blood pressure and cardiovascular disease. Med. Clin. N. Am. 2004, 88:63-82.
37. Standley P.R., Rose K.A., Sowers J.R. Increased basal arterial smooth muscle glucose transport in the Zucker rat. Am. J. Hypertens. 1995, 8:48-52.
38. Uemura H., Arisawa K., Hiyoshi M., Kitayama A., Takami H., Sawachika F., Dakeshita S., Nii K., Satoh H., Sumiyoshi Y., Morinaga K., Kodama K., Suzuki T., Nagai M., Suzuki T. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ. Health Perspect. 2009, 117:568-573.
39. United States Environmental Protection Agency (US EPA), 2010. Persistent Organic Pollutants: A Global Issue, A Global Response <> (accessed March 2010). http://www.epa.gov/oia/toxics/pop.htm#pops.
40. Van den Berg M., Birnbaum L., Bosveld A.T., Brunström B., Cook P., Feeley M., Giesy J.P., Hanberg A., Hasegawa R., Kennedy S.W., Kubiak T., Larsen J.C., van Leeuwen F.X., Liem A.K., Nolt C., Peterson R.E., Poellinger L., Safe S., Schrenk D., Tillitt D., Tysklind M., Younes M., Waern F., Zacharewski T. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 1998, 106:775-791.
41. Wang S.L., Tsai P.C., Yang C.Y., Guo Y. Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort. Diabetes Care 2008, 31:1574-1579.